Načítá se...
Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)
Imatinib (Gleevec) is a biological agent that is approved for the treatment of chronic myeloid leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most frequently seen adverse effects in patients treated with imatinib include superficial edema, muscle cramps, musculoskeletal pain, r...
Uloženo v:
| Vydáno v: | Cureus |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cureus
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5120973/ https://ncbi.nlm.nih.gov/pubmed/27909636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.848 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|